CytomX Therapeutics Inc (CTMX)
1.02
0.00 (0.00%)
USD |
NASDAQ |
Nov 27, 16:00
1.02
0.00 (0.00%)
After-Hours: 17:27
CytomX Therapeutics Shares Outstanding: 78.26M for Oct. 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
October 31, 2024 | 78.26M |
September 30, 2024 | 78.23M |
July 31, 2024 | 78.12M |
June 30, 2024 | 78.12M |
May 06, 2024 | 77.92M |
March 31, 2024 | 68.14M |
March 19, 2024 | 67.73M |
February 29, 2024 | 67.72M |
December 31, 2023 | 67.31M |
October 31, 2023 | 66.99M |
September 30, 2023 | 66.87M |
August 11, 2023 | 66.77M |
July 31, 2023 | 66.77M |
July 28, 2023 | 66.77M |
June 30, 2023 | 66.77M |
April 30, 2023 | 66.34M |
April 17, 2023 | 66.34M |
March 31, 2023 | 66.34M |
February 28, 2023 | 66.23M |
December 31, 2022 | 66.23M |
October 31, 2022 | 66.08M |
September 30, 2022 | 65.95M |
July 29, 2022 | 65.95M |
June 30, 2022 | 65.76M |
April 29, 2022 | 65.40M |
Date | Value |
---|---|
April 18, 2022 | 65.40M |
March 31, 2022 | 65.40M |
January 31, 2022 | 65.39M |
December 31, 2021 | 65.39M |
October 31, 2021 | 65.25M |
September 30, 2021 | 65.25M |
July 31, 2021 | 65.16M |
June 30, 2021 | 65.16M |
April 30, 2021 | 65.01M |
April 19, 2021 | 65.00M |
March 31, 2021 | 65.00M |
February 02, 2021 | 64.78M |
January 25, 2021 | 62.54M |
December 31, 2020 | 48.25M |
October 31, 2020 | 46.22M |
September 30, 2020 | 46.22M |
July 31, 2020 | 46.19M |
June 30, 2020 | 46.19M |
April 30, 2020 | 45.92M |
April 20, 2020 | 45.92M |
March 31, 2020 | 45.92M |
January 31, 2020 | 45.57M |
December 31, 2019 | 45.52M |
October 31, 2019 | 45.43M |
September 30, 2019 | 45.43M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
45.52M
Minimum
Dec 31 2019
78.26M
Maximum
Oct 31 2024
63.12M
Average
65.58M
Median
Shares Outstanding Benchmarks
Spero Therapeutics Inc | 54.52M |
NovaBay Pharmaceuticals Inc | 4.886M |
Palatin Technologies Inc | 19.55M |
iBio Inc | 9.150M |
Theriva Biologics Inc | 2.782M |